EUFETS

EUFETS (now BioNTech Innovative Manufacturing Services) is a specialized contract development and manufacturing organization (CDMO) focused on cell and gene therapies. Established in 1997 in Idar-Oberstein, Germany, the company was acquired by BioNTech in 2009 to bolster its internal manufacturing capabilities for innovative biopharmaceuticals. EUFETS provides a comprehensive range of services, including the production of GMP-grade viral vectors (retroviral and lentiviral), in vitro transcribed mRNA, and the genetic modification of primary cells. As a key component of BioNTech's infrastructure, it supports the development of individualized cancer immunotherapies and vaccines while continuing to serve external clients in the biotech and pharmaceutical industries. The company is recognized for its long-standing expertise in molecular biology and regulatory-compliant manufacturing processes.